AI isn’t close to curing cancer. Vivodyne says it knows what it will take; plus, TerraPower’s nuclear reactor has a secret weapon for powering AI data centers
TechCrunch Startup NewsShow Notes
A handful of AI-designed drugs have proceeded into human trials — one as far as Phase III, widespread human testing — but the reality is that the roadblocks aren’t necessarily ones that AI can solve today.
Also, TerraPower's nuclear power plant possesses a strategic advantage over competitors, especially when chasing after data center deals. Learn more about your ad choices. Visit podcastchoices.com/adchoices
More from TechCrunch Startup News
Just 9 months after raising an $180 million seed round, Flapping Airplanes has landed $1 billion Series A for its mission to build AI models "without ingesting half the internet."
Electric Plant has built an AI-powered translator to help humans listen to what plants are saying with the subtle electricity coursing through their stems.
Amazon wants to break Nvidia’s hold on PyTorch, the free toolkit used to build most AI apps, so that more developers run their apps on alternative chips like its own.
Counterfeiters are getting better at replicating brands' marks and passing off dupes, known as "superfakes," as genuine items. A startup called Veritas wants to tackle the problem with its own chip that verifies goods.
The Ricursive founders detailed how their startup is developing AI that can design chips, learn from each iteration, and improve subsequent designs, all with the goal of automating and accelerating the chip design process.